HOME › DRUGS › ELRANATAMAB
ACTIVE SUBSTANCE / INN

ELRANATAMAB

Brand name(s): Elrexfio, ELREXFIO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Multiple Myeloma
BLA761345
ACTIVE SUBSTANCE
Elranatamab
REGULATORS
FDA · EMA
SPONSORS / MAH
Pfizer Europe MA EEIG, PFIZER INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELREXFIOBLA761345PFIZER INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ElrexfioPfizer Europe MA EEIGAuthorised07/12/2023Multiple Myeloma

FULL INTELLIGENCE ON ELRANATAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →